Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · IEX Real-Time Price · USD
28.12
-0.20 (-0.71%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Akero Therapeutics Employees
Akero Therapeutics had 56 employees as of December 31, 2023. The number of employees increased by 18 or 47.37% compared to the previous year.
Employees
56
Change (1Y)
18
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$3,201,286
Market Cap
1.94B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 56 | 18 | 47.37% |
Dec 31, 2022 | 38 | 4 | 11.76% |
Dec 31, 2021 | 34 | 12 | 54.55% |
Dec 31, 2020 | 22 | 8 | 57.14% |
Dec 31, 2019 | 14 | 4 | 40.00% |
Dec 31, 2018 | 10 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Zai Lab | 2,175 |
Galapagos NV | 1,123 |
Veracyte | 815 |
RxSight | 374 |
Kiniksa Pharmaceuticals | 297 |
Mirum Pharmaceuticals | 264 |
Harmony Biosciences Holdings | 246 |
Neumora Therapeutics | 124 |
AKRO News
- 9 days ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Akero Therapeutics, Inc. (NASDAQ: AKRO) - PRNewsWire
- 4 weeks ago - Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. (“Akero”) (NASDAQ: AKRO) for Potential Violations of the Federal Securities Laws and Encourages Investors with Losses to Contact the Firm - GlobeNewsWire
- 4 weeks ago - AKRO Investors Have Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
- 4 weeks ago - FINAL AKRO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Akero Therapeutics, Inc. Investors to Join the Class Action Lawsuit! - Accesswire
- 4 weeks ago - AKRO Today Is the Last Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit - PRNewsWire
- 4 weeks ago - The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO) - Business Wire
- 4 weeks ago - SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO - PRNewsWire
- 4 weeks ago - AKRO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action – AKRO - GlobeNewsWire